FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy

FDA Rare Disease Day 2023: “Intersections with Rare Diseases – A patient focused event”Подробнее

Designing First-In-Human Trials for Small Molecules and BiologicsПодробнее

CMC Considerations for Oncolytic Viral Product DevelopmentПодробнее

Stem Cell Clinical Trials: Designing Preclinical Studies for First in Human Trials | Joy CavagnaroПодробнее

CMC Considerations for CAR T Cell Product DevelopmentПодробнее

SEND for CBER, What You Need to KnowПодробнее